Literature DB >> 17572098

Natural antioxidant compounds in risk factors for CVD.

Andriana C Kaliora1, George V Z Dedoussis.   

Abstract

The benefits of drug treating hypertension, hyperglycemia and hyperlipidemias in terms of reduction of CVD morbidity and mortality are well established. However, there is epidemiological evidence that consumption of certain foods results to a reduction in myocardial infarction markers. Given in many reviews is the impact of dietary antioxidants pertained to LDL oxidation and to vascular endothelial dysfunction. The potential of a diet rich in these compounds on the management of hypertension, hyperglycemia and hyperlipidemias is hereby criticized. Although their clinical use not always translates into clinical benefit, data are motivating. In the future, these agents may be very important complementary treatment options for subjects with high risk for CVD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17572098     DOI: 10.1016/j.phrs.2007.04.018

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  12 in total

1.  A multifunctional diet improves cardiometabolic-related biomarkers independently of weight changes: an 8-week randomized controlled intervention in healthy overweight and obese subjects.

Authors:  Juscelino Tovar; Maria Johansson; Inger Björck
Journal:  Eur J Nutr       Date:  2015-09-14       Impact factor: 5.614

Review 2.  Antioxidants, inflammation and cardiovascular disease.

Authors:  Harald Mangge; Kathrin Becker; Dietmar Fuchs; Johanna M Gostner
Journal:  World J Cardiol       Date:  2014-06-26

3.  The impact of fiber supplementation on ADMA levels.

Authors:  Dana E King; Mark DeLegge
Journal:  Nutr Clin Pract       Date:  2009 Feb-Mar       Impact factor: 3.080

4.  A diet based on multiple functional concepts improves cardiometabolic risk parameters in healthy subjects.

Authors:  Juscelino Tovar; Anne Nilsson; Maria Johansson; Rickard Ekesbo; Ann-Margreth Aberg; Ulla Johansson; Inger Björck
Journal:  Nutr Metab (Lond)       Date:  2012-04-02       Impact factor: 4.169

5.  Hepatoprotective and Hypolipidemic Effects of Satureja Khuzestanica Essential Oil in Alloxan-induced Type 1 Diabetic Rats.

Authors:  Hassan Ahmadvand; Majid Tavafi; Ali Reza Khalatbary
Journal:  Iran J Pharm Res       Date:  2012       Impact factor: 1.696

6.  Antiatherogenic, hepatoprotective, and hypolipidemic effects of coenzyme Q10 in alloxan-induced type 1 diabetic rats.

Authors:  Hassan Ahmadvand; Maryam Ghasemi-Dehnoo
Journal:  ARYA Atheroscler       Date:  2014-07

7.  Development and relative validation of a food frequency questionnaire for French-Canadian adolescent and young adult survivors of acute lymphoblastic leukemia.

Authors:  Sophia Morel; Olivia Portolese; Yasmine Chertouk; Jade Leahy; Laurence Bertout; Caroline Laverdière; Maja Krajinovic; Daniel Sinnett; Emile Levy; Valérie Marcil
Journal:  Nutr J       Date:  2018-04-21       Impact factor: 3.271

8.  Dietary Intakes Are Associated with HDL-Cholesterol in Survivors of Childhood Acute Lymphoblastic Leukaemia.

Authors:  Sophia Morel; Devendra Amre; Emma Teasdale; Maxime Caru; Caroline Laverdière; Maja Krajinovic; Daniel Sinnett; Daniel Curnier; Emile Levy; Valérie Marcil
Journal:  Nutrients       Date:  2019-12-05       Impact factor: 5.717

9.  Hepatoprotective Effects of Swimming Exercise against D-Galactose-Induced Senescence Rat Model.

Authors:  Chi-Chang Huang; Wen-Dee Chiang; Wen-Ching Huang; Chih-Yang Huang; Mei-Chich Hsu; Wan-Teng Lin
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-16       Impact factor: 2.629

Review 10.  Tocotrienol is a cardioprotective agent against ageing-associated cardiovascular disease and its associated morbidities.

Authors:  Nardev Ramanathan; Esther Tan; Li Jun Loh; Boon Seng Soh; Wei Ney Yap
Journal:  Nutr Metab (Lond)       Date:  2018-01-19       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.